Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Wearables in Clinical Trials: Many Benefits, and One Big Challenge

Posted on July 19th, 2017 by in Pharma R&D

 apple-watch-828827_640

The rapid development of wearable technology has the power to be a game-changer in many areas, including pharmaceutical R&D. Its most obvious use for pharma is in clinical trials, where recruiting is a frequent challenge, as is getting study participants to adhere to their therapeutic regime. Continue reading “Wearables in Clinical Trials: Many Benefits, and One Big Challenge” »

The certainty of uncertainty

Posted on July 17th, 2017 by in Pharma R&D

The recent election results in France and the UK once again show that a week is a long time in politics. Who would have thought when the UK voted to Brexit that Emmanuel Macron would sweep into power following the creation of his new political party in April 2016? Continue reading “The certainty of uncertainty” »

Precise Medicines: Matching Patients with the Most Effective Drugs

Posted on July 14th, 2017 by in Pharma R&D

Precision medicine is making us re-think the way we treat disease. Rather than selecting therapies based solely on the disease itself, doctors are increasingly considering the patient’s unique genomic and molecular make-up when determining treatment. Continue reading “Precise Medicines: Matching Patients with the Most Effective Drugs” »

Developing Child-Friendly Drugs

Posted on July 12th, 2017 by in Pharma R&D

In a recent article titled A Spoonful of Kids’ Medicine Makes the Profits Go Up, Kaiser Health News reporter Shefali Luthra wrote about how some pharma industry players may view the need for child-friendly versions of drugs as a “lucrative opportunity”. Luthra specifically cited the opportunities presented by laws like the Best Pharmaceuticals for Children Act Continue reading “Developing Child-Friendly Drugs” »

  1. 1
  2. 2